Oral vector vaccines target biothreats
Oral vector vaccines target biothreats
Chiarello, Kaylynn
6/1/2004
Pharmaceutical Technology
Since the 2001 terrorist attacks in the United States, U.S. governmental agencies have funded numerous multimillion-dollar biodefense projects. Among these projects are vaccine development programs aimed at biological agents such as plague, anthrax, tularemia, and small pox. In particular, several research groups working on oral anthrax vaccines have made significant advances in their projects, with many slated to begin clinical trials this year.
For example, researchers at the University of Maryland's Center for Vaccine Development (Baltimore, MD) are preparing a Phase I ...
?Read the Full Article, Sign up today?
Votes:14
Comments: 0